查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1908594

伴侣动物骨关节炎市场规模、份额和趋势分析报告：按产品、动物、给药途径、分销管道、地区和细分市场预测（2026-2033 年）

Companion Animal Osteoarthritis Market Size, Share & Trends Analysis Report By Product, By Animal, By Route Of Administration, Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

伴侣动物骨关节炎市场概览

2025年全球伴侣动物骨关节炎市场规模估计为29.8亿美元，预计2033年将达到52.2亿美元。

预计从 2026 年到 2033 年，该市场将以 6.46% 的复合年增长率成长。主要市场驱动因素包括宠物护理的进步、宠物拟人化程度的提高和宠物消费的增加、支持计划和倡议，以及全球宠物数量动态的变化。

伴侣动物骨关节炎（OA）治疗的进展正在改变兽医学的模式。随着兽医学的不断进步，骨关节炎的新治疗方法和治疗方法变得更加精准有效，从而改善了疾病的整体管理，并提高了患病宠物的生命品质。

更有效的药物、生技药品和非药物疗法的研发在这一发展过程中发挥关键作用。例如，近年来，再生医学，包括干细胞疗法和富血小板血浆（PRP）疗法，越来越受到关注。这些疗法在减轻骨关节炎关节发炎和促进癒合方面已显示出令人鼓舞的效果。这些治疗方法在兽医实践中越来越受欢迎，为宠物饲主提供了更多有效的治疗选择。根据美国兽医协会（AVMA）2024年2月发表的一篇报导，再生医学的进步显着改善了骨关节炎等关节疾病的治疗，有助于缓解宠物疼痛并提高其活动能力。此外，精准医疗的兴起，即根据个别宠物的需求量身定制治疗方案，也有助于优化骨关节炎的治疗管理。

这种方法能够实现更精准的诊断，并允许采用针对骨关节炎特异性病因而非仅仅缓解症状的治疗方法。随着兽医行业不断朝着更专业和个人化的护理模式发展，这些进步有望持续改善患有骨关节炎的宠物的治疗效果。 2023年5月5日，美国食品药物管理局（FDA）核准了Librera（bedinvetomab）用于治疗犬骨关节炎相关疼痛。这项核准标誌着兽医疼痛管理领域的重要进展，使Librera成为美国首个也是目前唯一一个用于治疗犬骨关节炎疼痛的每月一次的抗神经生长因子（NGF）单株抗体药物。此外，创新动物用药品和治疗方法的核准在推进伴侣动物骨关节炎的治疗方面发挥关键作用。与其他兽医领域类似，美国FDA等监管机构正越来越多地核准旨在改善关节健康的治疗方法。

兽医护理成本的上涨和宠物健康意识的增强，促使人们更加关注骨关节炎治疗领域的创新，从而推动了对先进解决方案的需求。宠物饲主越来越愿意投资于能够改善宠物生活品质的先进疗法，这进一步促进了骨关节炎护理市场的成长。根据Talker Research为MetLife进行的一项调查，预计到2024年，宠物饲主在宠物身上的平均支出将达到2,085.60美元。儘管通货膨胀加剧，但仍有36%的受访者预计2025年的支出将更高，显示人们越来越愿意在宠物健康方面进行投资。

这些持续的进步，加上宠物保险的日益普及和人们对动物健康的日益关注，预计将进一步推动对创新骨关节炎疗法的需求。随着兽医保健领域的不断发展和新技术的涌现，伴侣动物骨关节炎的治疗能力将不断提高，从而推动这个专业市场的进一步扩张。

目录

第一章调查方法和范围

第二章执行摘要

3. 伴侣动物骨关节炎市场的趋势与范围

  • 市场体系展望
    • 母市场
    • 相关市场
  • 市场动态
  • 伴侣动物骨关节炎市场分析工具
    • 波特五力分析
    • PESTEL 分析与 SWOT 分析
  • 主要国家和物种的动物数量估计（2021-2024 年）
  • 产品平臺分析

第四章 伴侣动物骨关节炎市场：产品、估算与趋势分析

  • 伴侣动物骨关节炎市场：依产品分類的差异分析
  • 伴侣动物骨关节炎市场规模及产品趋势分析（2021-2033）
  • 生技药品
    • 干细胞
    • 富血小板血浆（血小板血浆）
    • 单株抗体（mAbs）
    • 其他生技药品
  • 黏性补充剂
  • 製药
    • 类固醇
    • 非类固醇消炎剂（NSAIDs）
    • 其他的
  • 营养补充品
    • 软骨素
    • 葡萄糖胺
    • 甲基磺酰甲烷（MSM）
    • 透明质酸（HA）
    • Omega-3脂肪酸
    • 其他的

第五章 伴侣动物骨关节炎市场：按物种分類的估计和趋势分析

  • 伴侣动物骨关节炎市场：依动物类型分類的差异分析
  • 伴侣动物骨关节炎市场规模及趋势分析（依动物种类划分，2021-2033 年）
  • 狗
  • 猫
  • 马

6. 伴侣动物骨关节炎市场：依给药途径分類的估算与趋势分析

  • 伴侣动物骨关节炎市场：依给药途径分類的差异分析
  • 伴侣动物骨关节炎市场规模及趋势分析（依给药途径划分，2021-2033 年）
  • 口服
  • 注射
    • 肌肉内注射
    • 关节内
    • 其他注射药物
  • 其他的

7. 伴侣动物骨关节炎市场：按通路分類的估算与趋势分析

  • 伴侣动物骨关节炎市场：按通路分類的差异分析
  • 伴侣动物骨关节炎市场规模及趋势分析（依通路划分）（2021-2033 年）
  • 兽医院/诊所
  • 电子商务
  • 其他的

8. 伴侣动物骨关节炎市场：区域、预测与趋势分析

  • 区域仪錶板
  • 2025 年及 2033 年各地区伴侣动物骨关节炎市场占有率
  • 区域展望
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争情势

  • 市场参与企业分类
  • 公司特定市场分析/堆图分析
  • 公司简介
    • Zoetis
    • Boehringer Ingelheim
    • Elanco Animal Health
    • American Regent, Inc.
    • Merck Animal Health（Merck & Co. Inc）
    • Vetoquinol SA
    • Ceva Sante Animale
    • Virbac
    • Ardent Animal Health, Llc
    • PetVivo Holdings, Inc.（Spryng）
    • VetStem Inc.
    • Enso Discoveries
    • Contura Vet US
    • T-Cyte Therapeutics
    • Medrego Llc.
    • Biogenesis Bago
  • 主要企业列表
    • 製造商列表
    • 经销商列表
Product Code: GVR-4-68040-667-6

Companion Animal Osteoarthritis Market Summary

The global companion animal osteoarthritis market size was estimated at USD 2.98 billion in 2025 and is projected to reach USD 5.22 billion by 2033, growing at a CAGR of 6.46% from 2026 to 2033. The key market growth drivers include advancements in pet treatment, the increasing humanization of pets & expenditure on pets, support programs & initiatives, and changing pet demographics globally.

Advancements in osteoarthritis (OA) treatment for companion animals (CA) are transforming the landscape of veterinary care. With ongoing advancements in veterinary medicine, new therapies and treatment methods for osteoarthritis are becoming increasingly targeted and effective, thereby enhancing the overall management of the condition and improving the quality of life for affected pets.

The development of more effective medications, biologics, and non-pharmaceutical interventions is playing a significant role in this evolution. For example, in recent years, there has been a growing interest in regenerative medicine, including stem cell therapy and platelet-rich plasma (PRP), which have shown promising results in reducing inflammation and promoting healing in joints affected by osteoarthritis. These treatments have become increasingly accessible in veterinary practices, providing pet owners with more options for effective solutions for their pets. According to the American Veterinary Medical Association (AVMA) article in February 2024, advancements in regenerative medicine have significantly improved the treatment of joint conditions like osteoarthritis, helping pets manage pain and improve mobility. Additionally, the rise in precision medicine-where treatments are tailored to the specific needs of individual pets is helping optimize osteoarthritis management.

This approach enables more accurate diagnoses and the administration of therapies that specifically target the underlying causes of osteoarthritis, rather than merely alleviating symptoms. As the veterinary industry continues to evolve toward more specialized and individualized care, these advancements will likely continue to improve outcomes for pets with osteoarthritis. The U.S. Food and Drug Administration (FDA) approved Librela (bedinvetmab) for the control of pain associated with osteoarthritis in dogs on May 5, 2023. This approval marked a significant advancement in veterinary pain management, as Librela became the first and only once-monthly, anti-nerve growth factor (NGF) monoclonal antibody treatment for canine osteoarthritis pain in the United States. Furthermore, the approval of innovative veterinary drugs and treatment modalities plays a crucial role in advancing the osteoarthritis care for companion animals. Similar to the trend in other segments of animal health, regulatory bodies such as the U.S. FDA are approving more treatments aimed at improving joint health

The growing focus on innovation in the treatment of osteoarthritis, supported by rising veterinary care expenditures and increasing pet health awareness, is driving demand for advanced solutions. Pet owners are increasingly willing to invest in advanced treatments that enhance their pets' quality of life, driving greater market growth in osteoarthritis care. A survey by Talker Research for MetLife found that in 2024, the average pet parent spent USD 2,085.60 on their pets. Despite rising inflation, 36% of respondents anticipated spending even more in 2025, indicating a growing willingness to invest in pet health.

These ongoing advancements, combined with the growing adoption of pet insurance and increasing focus on animal health, are expected to further fuel demand for innovative osteoarthritis treatments. As the field of veterinary health evolves and new technologies emerge, the ability to better manage osteoarthritis in companion animals will continue to improve, driving further expansion of this specialized market.

Global Companion Animal Osteoarthritis Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the companion animal osteoarthritis market report based on product, animal, route of administration, distribution channel, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Biologics
    • Stem Cells
    • Platelet-Rich Plasma (PRP)
    • Monoclonal Antibodies (mAb)
    • Other Biologics
  • Viscosupplements
  • Pharmaceuticals
    • Steroids
    • NSAIDS
    • Others
  • Nutritional Supplements
    • Chondroitin
    • Glucosamine
    • Methylsulfonylmethane (MSM)
    • Hyaluronic Acid (HA)
    • Omega-3 Fatty Acids
    • Others
  • Animal Outlook (Revenue, USD Million, 2021 - 2033)
  • Canine
  • Equine
  • Feline
  • Route of Administration Outlook (Revenue, USD Million, 2021 - 2033)
  • Oral
  • Injectable
    • Intra-muscular
    • Intra-articular
    • Other Injectable
  • Others
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Veterinary Hospitals/Clinics
  • E-commerce
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • India
    • China
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
  • 1.4. Information/Data Analysis
  • 1.5. Market Formulation & Visualization
  • 1.6. Data Validation & Publishing
  • 1.7. Model Details
    • 1.7.1. Model 1 Analysis
    • 1.7.2. Model 2 Analysis
    • 1.7.3. Model 3 Analysis
  • 1.8. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Companion Animal Osteoarthritis Market Variable Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market
    • 3.1.2. Ancillary Market
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Advancements in Treatment for Pets
      • 3.2.1.2. Increasing Humanization of Pets & Expenditure on Pets
      • 3.2.1.3. Support Programs & Initiatives
      • 3.2.1.4. Changing Pet Demographics Globally
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Adverse Drug Reactions (ADR) in Treatments
      • 3.2.2.2. High Treatment Costs
      • 3.2.2.3. Complex Regulation Requirements
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. Companion Animal Osteoarthritis Market Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL by SWOT Analysis
  • 3.4. Estimated Animal Population, by Key Species, by Key Countries, 2021-2024
  • 3.5. Product Pipeline Analysis

Chapter 4. Companion Animal Osteoarthritis Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Companion Animal Osteoarthritis Market: Product Movement Analysis
  • 4.3. Companion Animal Osteoarthritis Market Size & Trend Analysis, by product, 2021 to 2033 (USD Million)
  • 4.4. Biologics
    • 4.4.1. Biologics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Stem Cells
      • 4.4.2.1. Stem Cells Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Platelet-Rich Plasma (PRP)
      • 4.4.3.1. Platelet-Rich Plasma (PRP) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.4. Monoclonal Antibodies (mAb)
      • 4.4.4.1. Monoclonal Antibodies (mAb) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.5. Other Biologics
      • 4.4.5.1. Other Biologics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Viscosupplements
    • 4.5.1. Viscosupplements Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Pharmaceuticals
    • 4.6.1. Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.2. Steroids
      • 4.6.2.1. Steroids Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.3. NSAIDs
      • 4.6.3.1. NSAIDs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.4. Others
      • 4.6.4.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Nutritional Supplements
    • 4.7.1. Nutritional Supplements Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.7.2. Chondroitin
      • 4.7.2.1. Chondroitin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.7.3. Glucosamine
      • 4.7.3.1. Glucosamine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.7.4. Methylsulfonylmethane (MSM)
      • 4.7.4.1. Methylsulfonylmethane (MSM) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.7.5. Hyaluronic Acid (HA)
      • 4.7.5.1. Hyaluronic Acid (HA) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.7.6. Omega-3 Fatty Acids
      • 4.7.6.1. Omega-3 Fatty Acids Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.7.7. Others
      • 4.7.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Companion Animal Osteoarthritis Market: Animal Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Companion Animal Osteoarthritis Market: Animal Movement Analysis
  • 5.3. Companion Animal Osteoarthritis Market Size & Trend Analysis, by animal, 2021 to 2033 (USD Million)
  • 5.4. Canine
    • 5.4.1. Canine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Feline
    • 5.5.1. Feline Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Equine
    • 5.6.1. Equine Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Companion Animal Osteoarthritis Market: Route of Administration Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Companion Animal Osteoarthritis Market: By Route of Administration Movement Analysis
  • 6.3. Companion Animal Osteoarthritis Market Size & Trend Analysis, by route of administration, 2021 to 2033 (USD Million)
  • 6.4. Oral
    • 6.4.1. Oral Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Injectable
    • 6.5.1. Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. Intra-muscular
      • 6.5.2.1. Intra-muscular Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. Intra-articular
      • 6.5.3.1. Intra-articular Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.4. Other Injectable
      • 6.5.4.1. Other Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Companion Animal Osteoarthritis Market: By Distribution Channel Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Companion Animal Osteoarthritis Market: By Distribution Channel Movement Analysis
  • 7.3. Companion Animal Osteoarthritis Market Size & Trend Analysis, by distribution channel, 2021 to 2033 (USD Million)
  • 7.4. Veterinary Hospitals/Clinics
    • 7.4.1. Veterinary Hospitals/Clinics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. E-commerce
    • 7.5.1. E-commerce Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Others
    • 7.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Companion Animal Osteoarthritis Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Dashboard
  • 8.2. Companion Animal Osteoarthritis Market Share, By Region, 2025 & 2033 (USD Million)
  • 8.3. Regional Outlook
  • 8.4. North America
    • 8.4.1. North America Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. U.S. Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Canada Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Mexico Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. UK Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Germany Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. France Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Italy Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Spain Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.7. Denmark
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Denmark Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.8. Sweden
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Competitive Scenario
      • 8.5.8.3. Regulatory Framework
      • 8.5.8.4. Sweden Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.9. Norway
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Competitive Scenario
      • 8.5.9.3. Regulatory Framework
      • 8.5.9.4. Norway Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Japan Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. China Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. India Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.6.5. Australia
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competitive Scenario
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Australia Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.6.6. South Korea
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Competitive Scenario
      • 8.6.6.3. Regulatory Framework
      • 8.6.6.4. South Korea Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Competitive Scenario
      • 8.6.7.3. Regulatory Framework
      • 8.6.7.4. Thailand Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. Brazil Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Argentina Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.8. Middle East & Africa
    • 8.8.1. Middle East & Africa Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Competitive Scenario
      • 8.8.2.3. Regulatory Framework
      • 8.8.2.4. South Africa Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Competitive Scenario
      • 8.8.3.3. Regulatory Framework
      • 8.8.3.4. Saudi Arabia Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. UAE Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Competitive Scenario
      • 8.8.5.3. Regulatory Framework
      • 8.8.5.4. Kuwait Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Company Market Position Analysis/ Heap Map Analysis
  • 9.3. Company Profiles
    • 9.3.1. Zoetis
      • 9.3.1.1. Participant's Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Product Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Boehringer Ingelheim
      • 9.3.2.1. Participant's Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Product Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. Elanco Animal Health
      • 9.3.3.1. Participant's Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Product Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. American Regent, Inc.
      • 9.3.4.1. Participant's Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Product Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Merck Animal Health (Merck & Co. Inc)
      • 9.3.5.1. Participant's Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Product Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Vetoquinol S.A.
      • 9.3.6.1. Participant's Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Product Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Ceva Sante Animale
      • 9.3.7.1. Participant's Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Product Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. Virbac
      • 9.3.8.1. Participant's Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Product Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. Ardent Animal Health, Llc
      • 9.3.9.1. Participant's Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Product Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. PetVivo Holdings, Inc. (Spryng)
      • 9.3.10.1. Participant's Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Product Benchmarking
      • 9.3.10.4. Strategic Initiatives
    • 9.3.11. VetStem Inc.
      • 9.3.11.1. Participant's Overview
      • 9.3.11.2. Financial Performance
      • 9.3.11.3. Product Benchmarking
      • 9.3.11.4. Strategic Initiatives
    • 9.3.12. Enso Discoveries
      • 9.3.12.1. Participant's Overview
      • 9.3.12.2. Financial Performance
      • 9.3.12.3. Product Benchmarking
      • 9.3.12.4. Strategic Initiatives
    • 9.3.13. Contura Vet US
      • 9.3.13.1. Participant's Overview
      • 9.3.13.2. Financial Performance
      • 9.3.13.3. Product Benchmarking
      • 9.3.13.4. Strategic Initiatives
    • 9.3.14. T-Cyte Therapeutics
      • 9.3.14.1. Participant's Overview
      • 9.3.14.2. Financial Performance
      • 9.3.14.3. Product Benchmarking
      • 9.3.14.4. Strategic Initiatives
    • 9.3.15. Medrego Llc.
      • 9.3.15.1. Participant's Overview
      • 9.3.15.2. Financial Performance
      • 9.3.15.3. Product Benchmarking
      • 9.3.15.4. Strategic Initiatives
    • 9.3.16. Biogenesis Bago
      • 9.3.16.1. Participant's Overview
      • 9.3.16.2. Financial Performance
      • 9.3.16.3. Product Benchmarking
      • 9.3.16.4. Strategic Initiatives
  • 9.4. List of Key Companies
    • 9.4.1. List of Manufacturers
    • 9.4.2. List of Distributors

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 4 Global Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 5 Global Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 6 Global Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 7 Global Companion Animal Osteoarthritis Market, by Region, 2021 - 2033 (USD Million)
  • Table 8 North America Companion Animal Osteoarthritis Market, by Country, 2021 - 2033 (USD Million)
  • Table 9 North America Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 10 North America Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 11 North America Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 12 North America Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 13 U.S. Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 14 U.S. Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 15 U.S. Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 16 U.S. Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 17 Canada Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 18 Canada Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 19 Canada Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 20 Canada Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 21 Mexico Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 22 Mexico Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 23 Mexico Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 24 Mexico Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 25 Europe Companion Animal Osteoarthritis Market, by Country, 2021 - 2033 (USD Million)
  • Table 26 Europe Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 27 Europe Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 28 Europe Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 29 Europe Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 30 UK Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 31 UK Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 32 UK Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 33 UK Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 34 Germany Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 35 Germany Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 36 Germany Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 37 Germany Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 38 France Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 39 France Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 40 France Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 41 France Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 42 Italy Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 43 Italy Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 44 Italy Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 45 Italy Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 46 Spain Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 47 Spain Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 48 Spain Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 49 Spain Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 50 Denmark Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 51 Denmark Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 52 Denmark Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 53 Denmark Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 54 Sweden Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 55 Sweden Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 56 Sweden Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 57 Sweden Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 58 Norway Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 59 Norway Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 60 Norway Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 61 Norway Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific Companion Animal Osteoarthritis Market, by Country, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 65 Asia Pacific Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 66 Asia Pacific Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 67 China Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 68 China Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 69 China Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 70 China Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 71 Japan Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 72 Japan Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 73 Japan Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 74 Japan Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 75 India Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 76 India Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 77 India Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 78 India Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 79 South Korea Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 80 South Korea Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 81 South Korea Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 82 South Korea Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 83 Australia Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 84 Australia Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 85 Australia Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 86 Australia Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 87 Thailand Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 88 Thailand Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 89 Thailand Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 90 Thailand Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 91 Latin America Companion Animal Osteoarthritis Market, by Country, 2021 - 2033 (USD Million)
  • Table 92 Latin America Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 93 Latin America Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 94 Latin America Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 95 Latin America Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 96 Brazil Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 97 Brazil Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 98 Brazil Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 99 Brazil Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 100 Brazil Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 101 Argentina Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 102 Argentina Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 103 Argentina Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 104 Middle East & Africa Companion Animal Osteoarthritis Market, by Country, 2021 - 2033 (USD Million)
  • Table 105 Middle East & Africa Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 106 Middle East & Africa Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 107 Middle East & Africa Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 108 Middle East & Africa Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 109 South Africa Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 110 South Africa Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 111 South Africa Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 112 South Africa Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 115 Saudi Arabia Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 116 Saudi Arabia Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 117 UAE Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 118 UAE Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 119 UAE Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 120 UAE Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 121 Kuwait Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 122 Kuwait Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 123 Kuwait Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 124 Kuwait Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Companion Animal Osteoarthritis Market, Market Segmentation
  • Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Regional Marketplace: Key Takeaways
  • Fig. 14 Global Companion Animal Osteoarthritis Market, for By Product, 2021 - 2033 (USD Million)
  • Fig. 15 Global Companion Animal Osteoarthritis Market, for Biologics, 2021 - 2033 (USD Million)
  • Fig. 16 Global Companion Animal Osteoarthritis Market, for Stem Cells, 2021 - 2033 (USD Million)
  • Fig. 17 Global Companion Animal Osteoarthritis Market, for Platelet-Rich Plasma (PRP), 2021 - 2033 (USD Million)
  • Fig. 18 Global Companion Animal Osteoarthritis Market, for Monoclonal Antibodies (mAb), 2021 - 2033 (USD Million)
  • Fig. 19 Global Companion Animal Osteoarthritis Market, for Other Biologics, 2021 - 2033 (USD Million)
  • Fig. 20 Global Companion Animal Osteoarthritis Market, for Viscosupplements, 2021 - 2033 (USD Million)
  • Fig. 21 Global Companion Animal Osteoarthritis Market, for Pharmaceuticals, 2021 - 2033 (USD Million)
  • Fig. 22 Global Companion Animal Osteoarthritis Market, for Steroids, 2021 - 2033 (USD Million)
  • Fig. 23 Global Companion Animal Osteoarthritis Market, for NSAIDS, 2021 - 2033 (USD Million)
  • Fig. 24 Global Companion Animal Osteoarthritis Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 25 Global Companion Animal Osteoarthritis Market, for Nutritional Supplements, 2021 - 2033 (USD Million)
  • Fig. 26 Global Companion Animal Osteoarthritis Market, for Chondroitin, 2021 - 2033 (USD Million)
  • Fig. 27 Global Companion Animal Osteoarthritis Market, for Glucosamine, 2021 - 2033 (USD Million)
  • Fig. 28 Global Companion Animal Osteoarthritis Market, for Methylsulfonylmethane (MSM), 2021 - 2033 (USD Million)
  • Fig. 29 Global Companion Animal Osteoarthritis Market, for Hyaluronic Acid (HA), 2021 - 2033 (USD Million)
  • Fig. 30 Global Companion Animal Osteoarthritis Market, for Omega-3 Fatty Acids, 2021 - 2033 (USD Million)
  • Fig. 31 Global Companion Animal Osteoarthritis Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 32 Global Companion Animal Osteoarthritis Market, for By Animal, 2021 - 2033 (USD Million)
  • Fig. 33 Global Companion Animal Osteoarthritis Market, for Canine, 2021 - 2033 (USD Million)
  • Fig. 34 Global Companion Animal Osteoarthritis Market, for Equine, 2021 - 2033 (USD Million)
  • Fig. 35 Global Companion Animal Osteoarthritis Market, for Feline, 2021 - 2033 (USD Million)
  • Fig. 36 Global Companion Animal Osteoarthritis Market, for By Route of Administration, 2021 - 2033 (USD Million)
  • Fig. 37 Global Companion Animal Osteoarthritis Market, for Oral, 2021 - 2033 (USD Million)
  • Fig. 38 Global Companion Animal Osteoarthritis Market, for Injectable, 2021 - 2033 (USD Million)
  • Fig. 39 Global Companion Animal Osteoarthritis Market, for Intra-muscular, 2021 - 2033 (USD Million)
  • Fig. 40 Global Companion Animal Osteoarthritis Market, for Intra-articular, 2021 - 2033 (USD Million)
  • Fig. 41 Global Companion Animal Osteoarthritis Market, for Other Injectable, 2021 - 2033 (USD Million)
  • Fig. 42 Global Companion Animal Osteoarthritis Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 43 Global Companion Animal Osteoarthritis Market, for By Distribution Channel, 2021 - 2033 (USD Million)
  • Fig. 44 Global Companion Animal Osteoarthritis Market, for Veterinary Hospitals/Clinics, 2021 - 2033 (USD Million)
  • Fig. 45 Global Companion Animal Osteoarthritis Market, for E-commerce, 2021 - 2033 (USD Million)
  • Fig. 46 Global Companion Animal Osteoarthritis Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 47 Regional Outlook, 2025 & 2033
  • Fig. 48 North America Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 49 U.S. Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 50 Canada Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 51 Mexico Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 52 Europe Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 53 UK Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 54 Germany Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 55 France Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 56 Italy Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 57 Spain Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 58 Sweden Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 59 Denmark Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 60 Norway Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 61 Asia Pacific Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 62 Japan Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 63 China Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 64 India Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 65 Australia Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 66 South Korea Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 67 Thailand Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 68 Latin America Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 69 Brazil Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 70 Argentina Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 71 Middle East and Africa Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 72 South Africa Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 73 Saudi Arabia Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 74 UAE Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 75 Kuwait Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)